Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro - Wikidata - awgldk - TriplyDB

Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro

Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro

http://www.wikidata.org/entity/Q35028805

about

Pharmacology of nociceptin and its receptor: a novel therapeutic target Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin Pre- and postsynaptic inhibition by nociceptin in guinea pig small intestinal myenteric plexus in vitro.Membrane-initiated estrogen signaling via Gq-coupled GPCR in the central nervous system.

P2860

Q24675084-2A727F51-6B9C-4D97-B64B-04D86345ADFA Q28363012-49E33D9C-D3BA-4B0B-8D2C-CD47021F21D6 Q35044107-943D8C7A-9F98-40A5-AD7A-7427F6C81C45 Q35044530-1037E28A-E06B-4413-A576-57246C466989 Q36744366-335FD76E-AEC2-4F24-9A9E-2FA13A1657D1 Q42699951-FC574AE7-DE74-4ABD-988E-DA378804A687 Q43260151-E8CAA2C0-6038-4EE5-93E1-4CCE50761503 Q43264475-03FE39E8-B45B-4902-A0C8-BCD6B13697A6 Q43641570-7D530B77-04E0-4294-8AA2-96CAD35E5323 Q49602618-F162AFA3-6FC9-4AD1-81AA-552AE5FDC7DB

P2860

Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro

http://www.wikidata.org/entity/Q35028805

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Further characterization of th ...... se in the mouse brain in vitro

@ast

Further characterization of th ...... se in the mouse brain in vitro

@en

type

label

Further characterization of th ...... se in the mouse brain in vitro

@ast

Further characterization of th ...... se in the mouse brain in vitro

@en

prefLabel

Further characterization of th ...... se in the mouse brain in vitro

@ast

Further characterization of th ...... se in the mouse brain in vitro

@en

P1433

Q35028805-659F084D-5577-4CB0-BF27-C5EEEC101665

P1476

Q35028805-96FDF318-6CB2-473A-8BF0-98EAF44E9569

P2093

Q35028805-06E7853A-6313-4384-AFD9-BB682C1F615C

Q35028805-18AE23D0-3D20-4772-B020-C63DE6D4DA51

Q35028805-53591CF5-58E1-41F3-9D4E-1D60510E257A

Q35028805-9505B672-A9D8-4141-9190-8F4362A529F6

Q35028805-C1FF9AEC-BC8B-4E34-A920-4DC9D6EF6829

P2860

Q35028805-01632578-F884-46EC-BDC1-BB012C35D167

Q35028805-04338EC5-19BA-438B-A50B-F761BAD3AD2D

Q35028805-075DC134-8ECC-4A24-81EF-D5E59E528B49

Q35028805-1B3537D0-AAB0-4708-99B0-495826AA9ED3

Q35028805-1D83F7CB-749D-4F8C-9EBC-CC1D484263FA

Q35028805-31EFEA2B-F5CC-414E-8CDA-A2892A893959

Q35028805-37804265-3AE5-4C2E-B338-E0B202EDF3D6

Q35028805-48D83B6F-C970-4CC3-AA6D-F455F3F8226C

Q35028805-4F3493C2-FA22-4DE8-A0BC-023C7BE6FEF1

Q35028805-5739167B-7D5C-49F9-B104-5968166EC6A1

P304

Q35028805-DAC284D7-EF02-495A-B7FE-622FBDE22E70

P31

Q35028805-3917A383-C1E1-4218-BFD4-6091DBBEC3EF

P356

Q35028805-91F509CE-07CD-4F46-8709-E32C8422A38C

P407

Q35028805-E6E9FC8C-055B-43E6-A5BE-2B6D9DC284B7

P433

Q35028805-98273EBD-1F78-4060-AA83-6A54A7C5643C

P478

Q35028805-942ECF42-B3F8-408D-865D-5344D879F947

P577

Q35028805-F447F02F-BDE4-499E-832C-43B39581405E

P5875

Q35028805-ECA7934D-C756-4047-9DEC-FE038B70361E

P698

Q35028805-8A1DE4C7-C189-4D71-9B85-EF837F5EFEDD

P932

Q35028805-3FC74DEF-FACB-468E-B78F-F9B83353D688

P356

P1433

British Journal of Pharmacology

P1476

Further characterization of th ...... se in the mouse brain in vitro

@en

P2093

E Schlicker

http://www.w3.org/2001/XMLSchema#string

M Kathmann

http://www.w3.org/2001/XMLSchema#string

M Nakazi

http://www.w3.org/2001/XMLSchema#string

S Werthwein

http://www.w3.org/2001/XMLSchema#string

U Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ

Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices

Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1.

Modulation of neurotransmitter release by presynaptic autoreceptors.

Modulation of transmitter and hormone release by multiple neuronal opioid receptors.

Single unit activity of brain monoamine-containing neurons in freely moving animals.

P304

300-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0702534

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12928552

http://www.w3.org/2001/XMLSchema#string

P698

10369486

http://www.w3.org/2001/XMLSchema#string

P932

1566004

http://www.w3.org/2001/XMLSchema#string